<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00111371</url>
  </required_header>
  <id_info>
    <org_study_id>LL-001; Project on Dyslexia</org_study_id>
    <nct_id>NCT00111371</nct_id>
  </id_info>
  <brief_title>Dopaminergic Enhancement of Learning and Memory in Healthy Adults and Patients With Dyslexia</brief_title>
  <official_title>Dopaminergic Enhancement of Learning and Memory (LL_001, Project on Dyslexia)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Muenster</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital Muenster</source>
  <brief_summary>
    <textblock>
      This study aims to determine whether levodopa, in combination with a high frequency training
      of (grammatical) rules, is effective in boosting learning success in healthy subjects and
      whether this kind of training in combination with levodopa improves reading and spelling
      abilities of patients with dyslexia.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Prior work by our group shows that d-amphetamine and the dopamine precursor levodopa markedly
      improve word learning success in healthy subjects. In this randomized, placebo-controlled,
      double-blind trial, we probe whether daily administration of levodopa, coupled with a
      training of grammatical rules, improves the training success in healthy adults as compared to
      placebo administration. In the second step of this study, patients with dyslexia will be
      trained with the identical protocol. We postulate that the combination of intensive training
      in language rules and levodopa improves the reading, writing, and spelling abilities of
      patients with dyslexia.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2005</start_date>
  <completion_date type="Anticipated">October 2015</completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Boost in training success (percent correct) through levodopa as compared to placebo</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>Boost in training success (reaction times) through levodopa as compared to placebo</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>Increased performance on reading, spelling and writing tests in dyslexic patients treated with levodopa as compared to placebo</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Stability of improvements one month post training</measure>
  </secondary_outcome>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Dyslexia</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Levodopa</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Right-handedness

          -  Age between 18-35 years

          -  Primary language: German

        Exclusion Criteria:

          -  Known allergy to levodopa or tetrazine

          -  History of medication/drug abuse

          -  Acute nicotine withdrawal or &gt; 10 cigarettes per day

          -  &gt;6 cups/glasses of coffee, caffeine drinks or energy drinks per day

          -  &gt;50 grams of alcohol per day

          -  Hypertonia

          -  Arteriosclerosis

          -  Diabetes, asthma, or glaucoma

          -  Psychiatric disease

          -  Neurologic disease

          -  Other medication
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stefan Knecht, Prof. Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dept. of Neurology, Universityclinic of Muenster</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Stefan Knecht, MD</last_name>
    <phone>+49-251-83</phone>
    <phone_ext>48195</phone_ext>
    <email>knecht@uni-muenster.de</email>
  </overall_contact>
  <location>
    <facility>
      <name>Dept. of Neurology, University Hospital of Muenster</name>
      <address>
        <city>Muenster</city>
        <state>North-Rhine Westphalia</state>
        <zip>48129</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stefan Knecht, Prof. Dr.</last_name>
      <phone>+49-251-83</phone>
      <phone_ext>48195</phone_ext>
      <email>knecht@uni-muenster.de</email>
    </contact>
    <investigator>
      <last_name>Stefan Knecht, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Knecht S, Breitenstein C, Bushuven S, Wailke S, Kamping S, Fl√∂el A, Zwitserlood P, Ringelstein EB. Levodopa: faster and better word learning in normal humans. Ann Neurol. 2004 Jul;56(1):20-6.</citation>
    <PMID>15236398</PMID>
  </reference>
  <reference>
    <citation>Breitenstein C, Knecht S. [Language acquisition and statistical learning]. Nervenarzt. 2003 Feb;74(2):133-43. Review. German.</citation>
    <PMID>12596014</PMID>
  </reference>
  <reference>
    <citation>Opitz B, Friederici AD. Brain correlates of language learning: the neuronal dissociation of rule-based versus similarity-based learning. J Neurosci. 2004 Sep 29;24(39):8436-40.</citation>
    <PMID>15456816</PMID>
  </reference>
  <verification_date>September 2006</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 19, 2005</study_first_submitted>
  <study_first_submitted_qc>May 19, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 20, 2005</study_first_posted>
  <last_update_submitted>December 4, 2014</last_update_submitted>
  <last_update_submitted_qc>December 4, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 5, 2014</last_update_posted>
  <keyword>artificial grammar learning</keyword>
  <keyword>dyslexia</keyword>
  <keyword>healthy subjects</keyword>
  <keyword>levodopa</keyword>
  <keyword>drug</keyword>
  <keyword>treatment</keyword>
  <keyword>intervention</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dyslexia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Levodopa</mesh_term>
    <mesh_term>Dopamine</mesh_term>
    <mesh_term>Dopamine Agents</mesh_term>
    <mesh_term>Dopamine Agonists</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

